Biosynthetic Technologies acquires Innoleo
Indianapolis-based Biosynthetic Technologies, which makes synthetic compounds called estolides from organic fatty acids found in various bio-derived oils, has acquired Innoleo, a specialist in castor oil and derivatives located in Ohio.
The products of both companies have applications in multiple industries, including personal care.
“The unique structure of castor oil offers interesting properties, making it appropriate for various industrial applications,” said Mark Miller, CEO at Biosynthetic Technologies. In particular, he noted, it is high in ricinoleic acid, making it suitable in a wide variety of applications, including personal care.